US FDA’s Breakthrough Designation Pace Slows, But Topics Broaden

 
• By Bridget Silverman

The 19 breakthrough therapy designations awarded so far this year run the gamut from areas that traditionally have not fared well with BTDs, like cardiovascular and respiratory disease, alongside the traditional cancer and orphan disease tentpoles.

Breakthrough slow down
The pace of designations for the fastest ways to get through FDA are slowing down. • Source: Nielsen Hobbs; the Pink Sheet| Shutterstock images

More from US FDA Performance Tracker

More from Regulatory Trackers